ClinicalTrialsFinder

ICANS Clinical Trials in Tianjin, Tianjin Municipality

1 recruitingTianjin, Tianjin Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study

Cytokine Release SyndromeICANS
Institute of Hematology & Blood Diseases Hospital, China18 enrolled1 locationNCT07169487